Vernon B Carruthers, PhD
Microbiology and Immunology
1550 West Medical Center Drive
Ann Arbor, MI 48109-5620
Manage Your Profile
About
Dr. Carruthers and his research team study the pathogenesis of toxoplasmosis, a disease of humans and animals caused by the protozoan parasite Toxoplasma gondii. A cousin of the malaria parasite, T. gondii causes congenital birth defects in infants, loss of vision in otherwise healthy adults or life threatening myocarditis or encephalitis in immunocompromised individuals. His team has discovered parasite virulence factors that function in host cell invasion, nutrient acquisition and lytic egress from host cells causing tissue damage and inflammation. His group has also defined new mechanisms of stage differentiation and persistence along with demonstrating the efficacy of novel experimental therapeutic compounds for treating the chronic phase of infection. After completing his PhD training in his native country Canada, Dr. Carruthers performed postdoctoral studies at The Rockefeller University and Washington University in St. Louis before launching his independent career as an Assistant Professor at the Johns Hopkins University Bloomberg School of Public Health. In 2006 he was recruited to the University of Michigan where he leads a team of 4-10 investigators as a tenured Professor and Associate Chair of the Department of Microbiology and Immunology. Dr. Carruthers has served on study sections for the National Institutes of Health, the American Cancer Society, the National Science Foundation, and the Howard Hughes Medical Institute, among other funding agencies. He has also fulfilled editorial duties for several journals including PLOS Pathogens and the Journal of Biological Chemistry. He is a former Director of the Molecular Mechanisms of Microbial Pathogenesis NIH T32 graduate training program and a former Associate Director for the Cellular and Molecular Biology graduate training program. Dr. Carruthers is a recipient of a UM Distinguished Faculty Acheivement Award, a Fredrick G. Novy Recognition Award, a Burroughs Wellcome New Investigator in Molecular Parasitology Award, and he is an elected Fellow of the American Academy of Microbiology and the American Association for the Advancement of Science. The Carruthers’ lab has appreciated >25 years of continuous funding from the National Institutes of Health and other funding agencies.
Links
Carruthers Lab
Qualifications
-
PhDWestern University, London, ON, Canada
1986 - 1990
-
BScUniversity of Victoria, Victoria, BC, Canada
1981 - 1985
Research Overview
Parasite nutrient acquisition via an ingestion pathway that exploits host ESCRT machinery
Regulating parasite stage differentiation through protein translation
Parasite manipulation of host organelles and cytoskeleton
Parasite persistence, particularly the role of autophagy during the chronic stage of infection
Drug development to cure chronic Toxoplasma infection
Recent Publications
-
Konishi R, Nakashima Y, Masatani T, Asada M, Hassan H, Fukuda K, Kuriyama S, Nishikawa Y, Kaneko O, Carruthers VB, Fujita A. Biochimica Et Biophysica Acta Biomembranes, 2027 Jan 1; 1869 (1):Journal ArticleParasitophorous vacuole membranes of Toxoplasma gondii and Plasmodium falciparum lack the lipid asymmetry characteristic of host cell plasma membranes
DOI:10.1016/j.bbamem.2026.184567 PMID: 42600824 -
Tachibana Y, Gu X, Sasai M, Kosako H, Takashima E, Standley DM, Carruthers VB, Soldati-Favre D, Yamamoto M. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleAn in vivo fitness gene of Toxoplasma, MIC11, is essential for PLP1-mediated egress from host cells
DOI:10.1038/s41467-026-71423-x PMID: 41935076 -
Konishi R, Nakashima Y, Masatani T, Asada M, Hassan H, Fukuda K, Kuriyama S, Nishikawa Y, Kaneko O, Carruthers VB, Fujita A. 2026 Aug 14; bioRxiv,PreprintParasitophorous vacuole membranes of Toxoplasma gondii and Plasmodium falciparum lack the lipid asymmetry characteristic of host cell plasma membranes
DOI:10.64898/2026.08.11.744334 -
Dong W, Wang F, Saladin BA, Leskaj S, Neupane R, Carruthers V, Querido JB. 2026 Jul 24;PreprintStructural basis for emetine inhibition of ribosome translocation in Toxoplasma gondii.
DOI:10.64898/2026.07.23.740346 PMID: 42539200 -
Kaur H, Guevara RB, Rivera-Cuevas Y, Olafsson EB, Mayoral J, Augusto L, Guerra AJ, Patel R, Bohannon KP, Sexton JZ, Hanson PI, Weiss LM, Carruthers VB. 2026 Jul 20;PreprintToxoplasma GRA8 engages the host ESCRT accessory protein ALG-2 and is necessary for parasite metabolic integrity.
DOI:10.64898/2026.07.20.739547 PMID: 42538958 -
Masci S, Thaprawat P, Piro F, Schultz TL, Carruthers VB, Di Cristina M. 2026 Jul 19;PreprintToxoplasma TgATG2 works with TgATG9 and TgProp1 to drive autophagic flux for parasite extracellular survival and persistence.
DOI:10.64898/2026.07.16.739079 PMID: 42523219 -
Olafsson EB, Arnold C-S, Kellermeier JA, Rimple PA, Kaur H, Wang Y, Sexton JZ, Svärd S, Carruthers VB, O'Meara MJ. 2026 Jul 9;PreprintA pooled image-based CRISPR screen identifies EAF1 as a T. gondii modulator of ESCRT subversion.
DOI:10.64898/2026.07.08.737057 PMID: 42465465 -
Borel TJ, Hitchens JR, Kaur H, Mueller D, Ard A, Carruthers VB, Clasby MC. Bioorganic and Medicinal Chemistry, 2026 Jul 1; 138:Journal ArticleImprovements in potency and selectivity of triazine nitrile inhibitors targeting Toxoplasma gondii cathepsin L for the treatment of latent toxoplasmosis
DOI:10.1016/j.bmc.2026.118643 PMID: 41962173
Featured News & Stories
Fengrong Wang, Ph.D., receives a Career-Starter Research Grant from Knights Templar Eye Foundation
Pariyamon (Pha) Thaprawat defended her Ph.D. thesis in M&I and is on her way to an M.D.